Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,575 | 588 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,270 | 108 | $0 (2024) |
| PFIZER INC. | $966.30 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $616.77 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $581.75 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $527.38 | 36 | $0 (2024) |
| Lilly USA, LLC | $431.72 | 28 | $0 (2024) |
| Amgen Inc. | $391.09 | 23 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $369.69 | 25 | $0 (2023) |
| ABBVIE INC. | $317.77 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $301.76 | 24 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $877.65 | 48 | AstraZeneca Pharmaceuticals LP ($146.17) |
| 2023 | $1,379 | 68 | Inari Medical, Inc. ($183.13) |
| 2022 | $1,115 | 70 | Novo Nordisk Inc ($150.75) |
| 2021 | $1,086 | 79 | PFIZER INC. ($170.63) |
| 2020 | $898.39 | 71 | Novo Nordisk Inc ($186.25) |
| 2019 | $900.47 | 65 | Novo Nordisk Inc ($179.06) |
| 2018 | $1,146 | 92 | Novo Nordisk Inc ($245.11) |
| 2017 | $1,178 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($243.48) |
All Payment Transactions
589 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Hematology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Oncology | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neuromodulation | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,794 | 2,932 | $387,685 | $163,665 |
| 2022 | 20 | 1,728 | 3,090 | $385,456 | $143,730 |
| 2021 | 16 | 1,694 | 3,005 | $359,889 | $146,484 |
| 2020 | 19 | 1,775 | 3,139 | $340,583 | $130,502 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 808 | $204,424 | $67,464 | 33.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 110 | 110 | $34,980 | $31,099 | 88.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $45,232 | $21,495 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 135 | $24,030 | $8,462 | 35.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 104 | 105 | $17,517 | $7,539 | 43.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 177 | 177 | $9,204 | $4,345 | 47.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 218 | 722 | $4,332 | $4,240 | 97.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 22 | $8,822 | $3,386 | 38.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 188 | 188 | $6,956 | $3,254 | 46.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 110 | 110 | $8,470 | $3,209 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 108 | 109 | $8,393 | $3,180 | 37.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 179 | 179 | $6,444 | $3,098 | 48.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 31 | 34 | $3,706 | $1,293 | 34.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 17 | $2,975 | $811.60 | 27.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 20 | $2,060 | $746.32 | 36.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 20 | $140.00 | $44.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 913 | $230,811 | $75,337 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 171 | 171 | $43,858 | $21,465 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 136 | $24,208 | $8,314 | 34.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 90 | 95 | $12,364 | $6,417 | 51.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 189 | 189 | $9,827 | $4,797 | 48.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 24 | 27 | $10,540 | $4,343 | 41.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 192 | 192 | $6,887 | $3,364 | 48.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 182 | 182 | $6,649 | $3,259 | 49.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 37 | 40 | $7,120 | $2,864 | 40.2% |
About Dr. Gregory Brooks, MD
Dr. Gregory Brooks, MD is a Family Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285724260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Brooks, MD has received a total of $8,580 in payments from pharmaceutical and medical device companies, with $877.65 received in 2024. These payments were reported across 589 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,575).
As a Medicare-enrolled provider, Brooks has provided services to 6,991 Medicare beneficiaries, totaling 12,166 services with total Medicare billing of $584,381. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hickory, NC
- Active Since 10/13/2006
- Last Updated 09/13/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285724260
Products in Payments
- TRELEGY ELLIPTA (Drug) $412.65
- Ozempic (Drug) $389.24
- ENTRESTO (Drug) $369.69
- Victoza (Drug) $308.49
- ELIQUIS (Drug) $306.87
- JARDIANCE (Drug) $304.01
- FARXIGA (Drug) $293.78
- XARELTO (Drug) $290.90
- Vascepa (Drug) $254.40
- BREZTRI (Drug) $250.59
- Kerendia (Drug) $212.07
- CHANTIX (Drug) $201.08
- FLOWTRIEVER CATHETER, S (Device) $183.13
- EVENITY (Biological) $178.98
- Saxenda (Drug) $173.10
- UBRELVY (Drug) $169.52
- Rybelsus (Drug) $168.87
- Prolia (Biological) $157.41
- VRAYLAR (Drug) $153.70
- OXTELLAR XR (Drug) $147.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hickory
Jonathan Wilson, Do, DO
Family Medicine — Payments: $31,125
Dr. Michael Desantis, M.d, M.D
Family Medicine — Payments: $12,291
David Duralia, M.d, M.D
Family Medicine — Payments: $11,991
Dr. Mary Britton, M.d, M.D
Family Medicine — Payments: $8,725
Robert Lee, Md, MD
Family Medicine — Payments: $8,629
Dr. Stephen Mcintyre, Md, MD
Family Medicine — Payments: $7,808